Upgrade to SI Premium - Free Trial

TD Cowen on Boston Scientific (BSX): 'Cyberattack To Weigh on Q3 Results; We Remain Bullish on the Setup for 2027'

October 20, 2026 9:14 AM
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $56.00 price target on Boston Scientific (NYSE: BSX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments